摘要 |
Compounds are provided which have the structure wherein Q is C or N; R<SUP>2a</SUP>, R<SUP>2b</SUP>, R<SUP>2c</SUP>, X<SUB>1 </SUB>to X<SUB>7</SUB>, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>3a</SUP>, R<SUP>4</SUP>, A, Y, m, and n are as defined herein, which compounds are useful as antidiabetic, hypolipidemic, and antiobesity agents. The present invention further provides a method for treating obesity and dyslipidemia in mammals including humans through simultaneous inhibition of peroxisome proliferator activated receptor-gamma (PPARgamma) and stimulation of peroxisome proliferator activated receptor-alpha (PPARalpha).
|